Physiologically responsive gene therapy

Molecular Medicine Today

Volumn 4, Issue 10, 1998, Pages 445-451

  Varley, Alan W ^a   Munford, Robert S ^a  

^a Molecular Host Defense Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION REGULATION; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; HUMAN; PROTEIN SYNTHESIS REGULATION; REVIEW;

ANIMALIA;

EID: 0031661337     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01333-1     Document Type: Review

References (36)

1. Walther W., Stein U. Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting. J. Mol. Med. 74:1996;379-392.
2. A-Mohammadi S., Hawkins R.E. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther. 5:1998;76-84.
3. White J.H. Modified steroid receptors and steroid-inducible promoters as genetic switches for gene therapy. Adv. Pharmacol. 40:1997;339-367.
4. Allgood V.E., Eastman E.M. Chimeric receptors as gene switches. Curr. Opin. Biotechnol. 8:1998;474-479.
5. Varley A.W., Geiszler S.M., Gaynor R.B., Munford R.S. A two-component expression system that responds to inflammatory stimuli in vivo. Nat. Biotechnol. 15:1997;1002-1006.
6. Kushner I. Regulation of the acute phase response by cytokines. Perspect. Biol. Med. 36:1993;611-622.
7. Varley A.W.et al. Inflammation-induced recombinant protein expression in vivo using promoters from acute phase protein genes. Proc. Natl. Acad. Sci. U. S. A. 92:1995;5346-5350.
8. Chen P.Q., Mayne M., Power C., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production - implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272:1997;22385-22388.
9. Scala G.et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 179:1994;961-971.
10. Westendorp M.O.et al. HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:1995;546-554.
11. Stinski M.F., Roehr T.J. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J. Virol. 55:1985;431-441.
12. Boshart M.et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 41:1985;521-530.
13. Mitanchez D., Doiron B., Chen R., Kahn A. Glucose-stimulated genes and prospects of gene therapy for type I diabetes. Endocrinol. Rev. 18:1997;520-540.
14. Clark S.A.et al. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes. 46:1997;958-967.
15. Hohmeier H.E.et al. Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes. 46:1998;968-977.
16. Chen R., Doiron B., Kahn A. Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector. FEBS Lett. 365:1995;223-226.
17. Gros L.et al. Regulated production of mature insulin by non-beta-cells. Hum. Gene Ther. 8:1997;2249-2259.
18. Kato I.et al. Enhancement of glucose-induced insulin secretion in transgenic mice overexpressing human VIP gene in pancreatic beta cells. Ann. New York Acad. Sci. 805:1996;232-242.
19. Khachatryan A.et al. Targeted expression of the neuropeptide calcitonin gene-related peptide to β cells prevents diabetes in NOD mice. J. Immunol. 158:1997;1409-1416.
20. Hohmeier H.E.et al. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J. Clin. Invest. 101:1998;1811-1820.
21. Rinsch C.et al. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Ther. 8:1997;1881-1889.
22. Prentice H.et al. Regulated expression of a foreign gene targeted to the ischaemic myocardium. Cardiovasc. Res. 35:1997;567-574.
23. Elliott M.J., Maini R.N., Feldmann M. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 344:1994;1105-1110.
24. Maini R.N., Brennan F.M., Williams R. TNF-α in rheumatoid arthritis and prospects of anti-TNF therapy. Clin. Exp. Rheumatol. 11(Suppl. 8):1995;S173-S175.
25. Zhang H.D.et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100:1997;1951-1957.
26. Le C.H., Nicolson A.G., Morales A., Sewell K.L. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor α receptor gene. Arthritis Rheum. 40:1997;1662-1669.
27. Makarov S.S.et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. U. S. A. 93:1996;402-406.
28. Kolls J., Peppel K., Silva M., Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. U. S. A. 91:1994;215-219.
29. Kolls J.K.et al. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171:1995;570-575.
30. Dusetti N.J.et al. The pancreatitis-associated protein I promoter allows targeting to the pancreas of a foreign gene, whose expression is up-regulated during pancreatic inflammation. J. Biol. Chem. 272:1997;5800-5804.
31. Qin L.et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation. 59:1995;809-816.
32. Verma I.M., Somla N. Gene therapy - promises, problems and prospects. Nature. 389:1998;239-242.
33. Kay M.A., Liu D., Hoogerbrugge P.M. Gene therapy. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12744-12746.
34. Chang T.M.S., Prakash S. Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today. 4:1998;221-226.
35. Hayashi Y., DePaoli A.M., Burant C.F., Refetoff S. Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J. Biol. Chem. 269:1994;23872-23875.
36. DeMatteo R.P.et al. Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter. J. Surg. Res. 72:1997;155-161.